MTNB - ViiV Healthcare to evaluate Matinas Bio's LNC platform May, 15 2019 12:10 PM Matinas Biopharma Holdings Inc. Matinas BioPharma (MTNB -0.3%) inks a research collaboration agreement with ViiV Healthcare under which the latter will explore the use of the former's lipid nano-crystal (LNC) platform delivery technology in developing new antivirals.More news on: Matinas BioPharma Holdings, Inc., GlaxoSmithKline plc, Pfizer Inc., Healthcare stocks news, Read more ...